Trademark Overview
On Friday, May 23, 2025, a trademark application was filed for IODAX with the United States Patent and Trademark Office. The USPTO has given the IODAX trademark a serial number of 79431008. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, August 28, 2025. This trademark is owned by Theranostik Pharma GmbH. The IODAX trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Radiopharmaceutical products; diagnostic radiopharmaceutical preparations; radioactive pharmaceutical preparations for in vivo diagnostics; radioactive pharmaceutical preparations for therapeutic use; radioactive substances for medical purposes; radioactive elements for medical use; sealed radioactive substances for medical use; radio-isotope markers for therapeutic or diagnostic use; radioactive preparations for veterinary diagnosis; radiological contrast substances for medical purposes; contrasting agents for diagnostic ultrasound imaging; diagnostic reagents and contrast media for medical use; diagnostic agents for pharmaceutical use; none of the aforesaid being in relation to medicines containing iron, oral iron compositions for the treatment of iron deficiency and/or anaemia.
Radioisotope therapy apparatus and instruments; radiation oncology apparatus for medical use; radio cardiographic apparatus for medical purposes; apparatus for radionuclide imaging.
Research in the field of interventional radiology; research relating to radiopharmaceuticals, radiotherapeutics and radiodiagnostics; development of radiopharmaceutical preparations and medications and radiodiagnostics and radiotherapeutics.
